Floatz logo

Sitagliptin

Optic Atrophy

Hadassah Medical OrganizationSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Optic Atrophy cohort.

Asset / SponsorPhaseRating
Deferiprone
Hadassah Medical Organization
Phase 2/3B
Metformin
Hadassah Medical Organization
Phase 2/3B
N-Acetyl-L-Cysteine
Hadassah Medical Organization
Phase 2/3B
Dantrolene
Washington University School of Medicine
Phase 1/2CCC

Same molecule, other indications

Sitagliptin is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →
prediabetes syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →